Home LiteratureArticle Details
PMID: 26207393 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't Review

Genetic perspective on the role of the autophagy-lysosome pathway in Parkinson disease.

Autophagy ·Vol. 11 ·No. 9 ·2015-00-00 ·Pages 1443-57

Gan-Or Z, Dion PA, Rouleau GA

Abstract

Parkinson disease (PD), once considered as a prototype of a sporadic disease, is now known to be considerably affected by various genetic factors, which interact with environmental factors and the normal process of aging, leading to PD. Large studies determined that the hereditary component of PD is at least 27%, and in some populations, single genetic factors are responsible for more than 33% of PD patients. Interestingly, many of these genetic factors, such as LRRK2, GBA, SMPD1, SNCA, PARK2, PINK1, PARK7, SCARB2, and others, are involved in the autophagy-lysosome pathway (ALP). Some of these genes encode lysosomal enzymes, whereas others correspond to proteins that are involved in transport to the lysosome, mitophagy, or other autophagic-related functions. Is it possible that all these factors converge into a single pathway that causes PD? In this review, we will discuss these genetic findings and the role of the ALP in the pathogenesis of PD and will try to answer this question. We will suggest a novel hypothesis for the pathogenic mechanism of PD that involves the lysosome and the different autophagy pathways.

Keywords
GBA LAMP2A LRRK2 Parkinson disease SNCA autophagy genetics lysosome mitophagy
MeSH Terms
Animals Autophagy/genetics Genetic Predisposition to Disease Genome-Wide Association Study Humans Lysosomal Storage Diseases/genetics Lysosomes/genetics Parkinson Disease/genetics
Authors & Affiliations
3 authors, click to expand affiliations / ORCID
Gan-Or Ziv
a The Department of Human Genetics ; McGill University ; Montreal , QC Canada. | b Montreal Neurological Institute; McGill University ; Montreal , QC Canada.
Dion Patrick A
a The Department of Human Genetics ; McGill University ; Montreal , QC Canada. | b Montreal Neurological Institute; McGill University ; Montreal , QC Canada. | c The Department of Neurology & Neurosurgery ; McGill University ; Montreal , QC Canada.
Rouleau Guy A
a The Department of Human Genetics ; McGill University ; Montreal , QC Canada. | b Montreal Neurological Institute; McGill University ; Montreal , QC Canada. | c The Department of Neurology & Neurosurgery ; McGill University ; Montreal , QC Canada.
References (207)
207 references, click to expand
  1. The glucocerebrosidase gene and Parkinson's disease in Ashkenazi Jews.
    N Engl J Med. 2005 Feb 17;352(7):728-31; author reply 728-31 PMID: 15719452
  2. TFEB-mediated autophagy rescues midbrain dopamine neurons from α-synuclein toxicity.
    Proc Natl Acad Sci U S A. 2013 May 7;110(19):E1817-26 PMID: 23610405
  3. Occurrence of Parkinson's syndrome in type I Gaucher disease.
    QJM. 1996 Sep;89(9):691-4 PMID: 8917744
  4. The Parkinson's disease-linked proteins Fbxo7 and Parkin interact to mediate mitophagy.
    Nat Neurosci. 2013 Sep;16(9):1257-65 PMID: 23933751
  5. An extended proteome map of the lysosomal membrane reveals novel potential transporters.
    Mol Cell Proteomics. 2013 Jun;12(6):1572-88 PMID: 23436907
  6. Impairment of starvation-induced and constitutive autophagy in Atg7-deficient mice.
    J Cell Biol. 2005 May 9;169(3):425-34 PMID: 15866887
  7. Metabolic activity determines efficacy of macroautophagic clearance of pathological oligomeric alpha-synuclein.
    Am J Pathol. 2009 Aug;175(2):736-47 PMID: 19628769
  8. Gaucher disease: mutation and polymorphism spectrum in the glucocerebrosidase gene (GBA).
    Hum Mutat. 2008 May;29(5):567-83 PMID: 18338393
  9. Meta-analysis of Parkinson's disease: identification of a novel locus, RIT2.
    Ann Neurol. 2012 Mar;71(3):370-84 PMID: 22451204
  10. Inhibitors of leucine-rich repeat kinase-2 protect against models of Parkinson's disease.
    Nat Med. 2010 Sep;16(9):998-1000 PMID: 20729864
  11. The melanoma-associated transmembrane glycoprotein Gpnmb controls trafficking of cellular debris for degradation and is essential for tissue repair.
    FASEB J. 2010 Dec;24(12):4767-81 PMID: 20709912
  12. A role of Rab29 in the integrity of the trans-Golgi network and retrograde trafficking of mannose-6-phosphate receptor.
    PLoS One. 2014;9(5):e96242 PMID: 24788816
  13. ATP13A2 mutations impair mitochondrial function in fibroblasts from patients with Kufor-Rakeb syndrome.
    Neurobiol Aging. 2012 Aug;33(8):1843.e1-7 PMID: 22296644
  14. Hereditary parkinsonism with dementia is caused by mutations in ATP13A2, encoding a lysosomal type 5 P-type ATPase.
    Nat Genet. 2006 Oct;38(10):1184-91 PMID: 16964263
  15. Role of autophagy in G2019S-LRRK2-associated neurite shortening in differentiated SH-SY5Y cells.
    J Neurochem. 2008 May;105(3):1048-56 PMID: 18182054
  16. CNS expression of glucocerebrosidase corrects alpha-synuclein pathology and memory in a mouse model of Gaucher-related synucleinopathy.
    Proc Natl Acad Sci U S A. 2011 Jul 19;108(29):12101-6 PMID: 21730160
  17. Retromer-mediated endosomal protein sorting: all WASHed up!
    Trends Cell Biol. 2013 Nov;23(11):522-8 PMID: 23721880
  18. Mitofusin 1 and mitofusin 2 are ubiquitinated in a PINK1/parkin-dependent manner upon induction of mitophagy.
    Hum Mol Genet. 2010 Dec 15;19(24):4861-70 PMID: 20871098
  19. Aberrant interaction between Parkinson disease-associated mutant UCH-L1 and the lysosomal receptor for chaperone-mediated autophagy.
    J Biol Chem. 2008 Aug 29;283(35):23731-8 PMID: 18550537
  20. Slowing of neurodegeneration in Parkinson's disease and Huntington's disease: future therapeutic perspectives.
    Lancet. 2014 Aug 9;384(9942):545-55 PMID: 24954676
  21. Lower motor neuron disease with respiratory failure caused by a novel MAPT mutation.
    Neurology. 2014 Jun 3;82(22):1990-8 PMID: 24808015
  22. SREBF1 links lipogenesis to mitophagy and sporadic Parkinson disease.
    Autophagy. 2014 Aug;10(8):1476-7 PMID: 24991824
  23. Hematologically important mutations: Gaucher disease.
    Blood Cells Mol Dis. 2005 Nov-Dec;35(3):355-64 PMID: 16185900
  24. Abberant alpha-synuclein confers toxicity to neurons in part through inhibition of chaperone-mediated autophagy.
    PLoS One. 2009;4(5):e5515 PMID: 19436756
  25. Trehalose, a novel mTOR-independent autophagy enhancer, accelerates the clearance of mutant huntingtin and alpha-synuclein.
    J Biol Chem. 2007 Feb 23;282(8):5641-52 PMID: 17182613
  26. The role of innate and adaptive immunity in Parkinson's disease.
    J Parkinsons Dis. 2013;3(4):493-514 PMID: 24275605
  27. Unbiased screen for interactors of leucine-rich repeat kinase 2 supports a common pathway for sporadic and familial Parkinson disease.
    Proc Natl Acad Sci U S A. 2014 Feb 18;111(7):2626-31 PMID: 24510904
  28. The PINK1/Parkin-mediated mitophagy is compromised by PD-associated mutations.
    Autophagy. 2010 Oct;6(7):871-8 PMID: 20798600
  29. Heterozygous Niemann-Pick disease type C presenting with tremor.
    Neurology. 2004 Dec 14;63(11):2189-90 PMID: 15596783
  30. Acid β-glucosidase mutants linked to Gaucher disease, Parkinson disease, and Lewy body dementia alter α-synuclein processing.
    Ann Neurol. 2011 Jun;69(6):940-53 PMID: 21472771
  31. A novel α-synuclein missense mutation in Parkinson disease.
    Neurology. 2013 Mar 12;80(11):1062-4 PMID: 23427326
  32. Lysosomal enzyme cathepsin D protects against alpha-synuclein aggregation and toxicity.
    Mol Brain. 2008;1:17 PMID: 19021916
  33. Autophagic cell death: the story of a misnomer.
    Nat Rev Mol Cell Biol. 2008 Dec;9(12):1004-10 PMID: 18971948
  34. Parkinsonism syndrome in heterozygotes for Niemann-Pick C1.
    J Neurol Sci. 2013 Dec 15;335(1-2):219-20 PMID: 24035292
  35. The role of variation at AβPP, PSEN1, PSEN2, and MAPT in late onset Alzheimer's disease.
    J Alzheimers Dis. 2012;28(2):377-87 PMID: 22027014
  36. PINK1-phosphorylated mitofusin 2 is a Parkin receptor for culling damaged mitochondria.
    Science. 2013 Apr 26;340(6131):471-5 PMID: 23620051
  37. Canonical interaction of cyclin G associated kinase with adaptor protein 1 regulates lysosomal enzyme sorting.
    Mol Biol Cell. 2007 Aug;18(8):2991-3001 PMID: 17538018
  38. Genetic analysis implicates APOE, SNCA and suggests lysosomal dysfunction in the etiology of dementia with Lewy bodies.
    Hum Mol Genet. 2014 Dec 1;23(23):6139-46 PMID: 24973356
  39. The Sac1 domain of SYNJ1 identified mutated in a family with early-onset progressive Parkinsonism with generalized seizures.
    Hum Mutat. 2013 Sep;34(9):1200-7 PMID: 23804563
  40. ROS-dependent regulation of Parkin and DJ-1 localization during oxidative stress in neurons.
    Hum Mol Genet. 2012 Nov 15;21(22):4888-903 PMID: 22872702
  41. Glucocerebrosidase inhibition causes mitochondrial dysfunction and free radical damage.
    Neurochem Int. 2013 Jan;62(1):1-7 PMID: 23099359
  42. Risk tables for parkinsonism and Parkinson's disease.
    J Clin Epidemiol. 2002 Jan;55(1):25-31 PMID: 11781119
  43. The downward spiral of tau and autolysosomes: a new hypothesis in neurodegeneration.
    Autophagy. 2012 Jul 1;8(7):1144-5 PMID: 22635052
  44. Genetic evidence for the involvement of tau in progressive supranuclear palsy.
    Ann Neurol. 1997 Feb;41(2):277-81 PMID: 9029080
  45. Altered dynamics of the lysosomal receptor for chaperone-mediated autophagy with age.
    J Cell Sci. 2007 Mar 1;120(Pt 5):782-91 PMID: 17284523
  46. Mitochondria and quality control defects in a mouse model of Gaucher disease--links to Parkinson's disease.
    Cell Metab. 2013 Jun 4;17(6):941-53 PMID: 23707074
  47. Mutations in the DJ-1 gene associated with autosomal recessive early-onset parkinsonism.
    Science. 2003 Jan 10;299(5604):256-9 PMID: 12446870
  48. Phenotypic variation in a large Swedish pedigree due to SNCA duplication and triplication.
    Neurology. 2007 Mar 20;68(12):916-22 PMID: 17251522
  49. Mitochondrial dynamics and inheritance during cell division, development and disease.
    Nat Rev Mol Cell Biol. 2014 Oct;15(10):634-46 PMID: 25237825
  50. Large-scale meta-analysis of genome-wide association data identifies six new risk loci for Parkinson's disease.
    Nat Genet. 2014 Sep;46(9):989-93 PMID: 25064009
  51. Threonine 56 phosphorylation of Bcl-2 is required for LRRK2 G2019S-induced mitochondrial depolarization and autophagy.
    Biochim Biophys Acta. 2015 Jan;1852(1):12-21 PMID: 25446991
  52. Interplay of LRRK2 with chaperone-mediated autophagy.
    Nat Neurosci. 2013 Apr;16(4):394-406 PMID: 23455607
  53. The heritability of risk and age at onset of Parkinson's disease after accounting for known genetic risk factors.
    J Hum Genet. 2010 Apr;55(4):241-3 PMID: 20203693
  54. DNAJC13 mutations in Parkinson disease.
    Hum Mol Genet. 2014 Apr 1;23(7):1794-801 PMID: 24218364
  55. Intracellular processing of disease-associated α-synuclein in the human brain suggests prion-like cell-to-cell spread.
    Neurobiol Dis. 2014 Sep;69:76-92 PMID: 24878508
  56. Tau fragmentation, aggregation and clearance: the dual role of lysosomal processing.
    Hum Mol Genet. 2009 Nov 1;18(21):4153-70 PMID: 19654187
  57. The role of glucocerebrosidase mutations in Parkinson disease and Lewy body disorders.
    Curr Neurol Neurosci Rep. 2010 May;10(3):190-8 PMID: 20425034
  58. Macroautophagy in sporadic and the genetic form of Parkinson's disease with the A53T α-synuclein mutation.
    Transl Neurodegener. 2012 Jan 13;1(1):2 PMID: 23210740
  59. Emerging pathways in genetic Parkinson's disease: Potential role of ceramide metabolism in Lewy body disease.
    FEBS J. 2008 Dec;275(23):5767-73 PMID: 19021754
  60. Meta-analysis of the relationship between Parkinson disease and melanoma.
    Neurology. 2011 Jun 7;76(23):2002-9 PMID: 21646627
  61. Mutation in the SYNJ1 gene associated with autosomal recessive, early-onset Parkinsonism.
    Hum Mutat. 2013 Sep;34(9):1208-15 PMID: 23804577
  62. VPS35 mutations in Parkinson disease.
    Am J Hum Genet. 2011 Jul 15;89(1):162-7 PMID: 21763482
  63. Genome-wide association study reveals genetic risk underlying Parkinson's disease.
    Nat Genet. 2009 Dec;41(12):1308-12 PMID: 19915575
  64. A common LRRK2 mutation in idiopathic Parkinson's disease.
    Lancet. 2005 Jan 29-Feb 4;365(9457):415-6 PMID: 15680457
  65. Defective quality control mechanisms and accumulation of damaged mitochondria link Gaucher and Parkinson diseases.
    Autophagy. 2013 Oct;9(10):1633-5 PMID: 23989665
  66. LAMP3 is involved in tamoxifen resistance in breast cancer cells through the modulation of autophagy.
    Endocr Relat Cancer. 2014 Feb;21(1):101-12 PMID: 24434718
  67. LIMP-2 expression is critical for β-glucocerebrosidase activity and α-synuclein clearance.
    Proc Natl Acad Sci U S A. 2014 Oct 28;111(43):15573-8 PMID: 25316793
  68. Homeostatic levels of p62 control cytoplasmic inclusion body formation in autophagy-deficient mice.
    Cell. 2007 Dec 14;131(6):1149-63 PMID: 18083104
  69. Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism.
    Nature. 1998 Apr 9;392(6676):605-8 PMID: 9560156
  70. Mutation in VPS35 associated with Parkinson's disease impairs WASH complex association and inhibits autophagy.
    Nat Commun. 2014;5:3828 PMID: 24819384
  71. Differential effects of severe vs mild GBA mutations on Parkinson disease.
    Neurology. 2015 Mar 3;84(9):880-7 PMID: 25653295
  72. Association of glucocerebrosidase mutations with dementia with lewy bodies.
    Arch Neurol. 2009 May;66(5):578-83 PMID: 19433657
  73. PARK9-associated ATP13A2 localizes to intracellular acidic vesicles and regulates cation homeostasis and neuronal integrity.
    Hum Mol Genet. 2012 Apr 15;21(8):1725-43 PMID: 22186024
  74. GBA mutations increase risk for Lewy body disease with and without Alzheimer disease pathology.
    Neurology. 2012 Nov 6;79(19):1944-50 PMID: 23035075
  75. Glucocerebrosidase depletion enhances cell-to-cell transmission of α-synuclein.
    Nat Commun. 2014;5:4755 PMID: 25156829
  76. The chaperone-mediated autophagy receptor organizes in dynamic protein complexes at the lysosomal membrane.
    Mol Cell Biol. 2008 Sep;28(18):5747-63 PMID: 18644871
  77. Rare lysosomal enzyme gene SMPD1 variant (p.R591C) associates with Parkinson's disease.
    Neurobiol Aging. 2013 Dec;34(12):2890.e13-5 PMID: 23871123
  78. Genome-wide association study identifies common variants at four loci as genetic risk factors for Parkinson's disease.
    Nat Genet. 2009 Dec;41(12):1303-7 PMID: 19915576
  79. PINK1/Parkin-mediated mitophagy is dependent on VDAC1 and p62/SQSTM1.
    Nat Cell Biol. 2010 Feb;12(2):119-31 PMID: 20098416
  80. A new F-box protein 7 gene mutation causing typical Parkinson's disease.
    Mov Disord. 2015 Jul;30(8):1130-3 PMID: 26010069
  81. Frequency of the D620N mutation in VPS35 in Parkinson disease.
    Arch Neurol. 2012 Oct;69(10):1360-4 PMID: 22801713
  82. Decreased expression of lysosomal alpha-galactosiase A gene in sporadic Parkinson's disease.
    Neurochem Res. 2011 Oct;36(10):1939-44 PMID: 21643977
  83. Argyrophilic grain disease is a sporadic 4-repeat tauopathy.
    J Neuropathol Exp Neurol. 2002 Jun;61(6):547-56 PMID: 12071638
  84. Alpha-Synuclein is degraded by both autophagy and the proteasome.
    J Biol Chem. 2003 Jul 4;278(27):25009-13 PMID: 12719433
  85. Analysis of GWAS-linked loci in Parkinson disease reaffirms PARK16 as a susceptibility locus.
    Neurology. 2010 Aug 10;75(6):508-12 PMID: 20697102
  86. Mutation in the alpha-synuclein gene identified in families with Parkinson's disease.
    Science. 1997 Jun 27;276(5321):2045-7 PMID: 9197268
  87. Using genome-wide complex trait analysis to quantify 'missing heritability' in Parkinson's disease.
    Hum Mol Genet. 2012 Nov 15;21(22):4996-5009 PMID: 22892372
  88. Novel ethyl methanesulfonate (EMS)-induced null alleles of the Drosophila homolog of LRRK2 reveal a crucial role in endolysosomal functions and autophagy in vivo.
    Dis Model Mech. 2014 Dec;7(12):1351-63 PMID: 25288684
  89. alpha-Synuclein locus triplication causes Parkinson's disease.
    Science. 2003 Oct 31;302(5646):841 PMID: 14593171
  90. Screening for VPS35 mutations in Parkinson's disease.
    Neurobiol Aging. 2012 Apr;33(4):838.e1-5 PMID: 22154191
  91. Genetic analysis of lysosomal alpha-galactosidase A gene in sporadic Parkinson's disease.
    Neurosci Lett. 2011 Aug 1;500(1):31-5 PMID: 21683120
  92. Loss of leucine-rich repeat kinase 2 causes impairment of protein degradation pathways, accumulation of alpha-synuclein, and apoptotic cell death in aged mice.
    Proc Natl Acad Sci U S A. 2010 May 25;107(21):9879-84 PMID: 20457918
  93. Autophagy in cell death: an innocent convict?
    J Clin Invest. 2005 Oct;115(10):2679-88 PMID: 16200202
  94. Glucocerebrosidase is shaking up the synucleinopathies.
    Brain. 2014 May;137(Pt 5):1304-22 PMID: 24531622
  95. G51D α-synuclein mutation causes a novel parkinsonian-pyramidal syndrome.
    Ann Neurol. 2013 Apr;73(4):459-71 PMID: 23526723
  96. PINK1-dependent recruitment of Parkin to mitochondria in mitophagy.
    Proc Natl Acad Sci U S A. 2010 Jan 5;107(1):378-83 PMID: 19966284
  97. MPTP toxicity: implications for research in Parkinson's disease.
    Annu Rev Neurosci. 1988;11:81-96 PMID: 3129982
  98. Control of autophagy maturation by acid sphingomyelinase in mouse coronary arterial smooth muscle cells: protective role in atherosclerosis.
    J Mol Med (Berl). 2014 May;92(5):473-85 PMID: 24463558
  99. A mutation in VPS35, encoding a subunit of the retromer complex, causes late-onset Parkinson disease.
    Am J Hum Genet. 2011 Jul 15;89(1):168-75 PMID: 21763483
  100. Identification of VPS35 mutations replicated in French families with Parkinson disease.
    Neurology. 2012 May 1;78(18):1449-50 PMID: 22517097
  101. Wild type alpha-synuclein is degraded by chaperone-mediated autophagy and macroautophagy in neuronal cells.
    J Biol Chem. 2008 Aug 29;283(35):23542-56 PMID: 18566453
  102. Disruption of clathrin-mediated trafficking causes centrosome overduplication and senescence.
    Traffic. 2014 Jan;15(1):60-77 PMID: 24138026
  103. Hereditary early-onset Parkinson's disease caused by mutations in PINK1.
    Science. 2004 May 21;304(5674):1158-60 PMID: 15087508
  104. Retrograde transport from endosomes to the trans-Golgi network.
    Nat Rev Mol Cell Biol. 2006 Aug;7(8):568-79 PMID: 16936697
  105. Neuronopathic Gaucher disease in the mouse: viable combined selective saposin C deficiency and mutant glucocerebrosidase (V394L) mice with glucosylsphingosine and glucosylceramide accumulation and progressive neurological deficits.
    Hum Mol Genet. 2010 Mar 15;19(6):1088-97 PMID: 20047948
  106. Glucocerebrosidase deficiency in substantia nigra of parkinson disease brains.
    Ann Neurol. 2012 Sep;72(3):455-63 PMID: 23034917
  107. Role of tau protein in neuronal damage in Alzheimer's disease and Down syndrome.
    Arch Med Res. 2012 Nov;43(8):645-54 PMID: 23142525
  108. Reduced glucocerebrosidase is associated with increased α-synuclein in sporadic Parkinson's disease.
    Brain. 2014 Mar;137(Pt 3):834-48 PMID: 24477431
  109. Association of Parkinson disease to PARK16 in a Chilean sample.
    Parkinsonism Relat Disord. 2011 Jan;17(1):70-1 PMID: 20934365
  110. Disrupted autophagy leads to dopaminergic axon and dendrite degeneration and promotes presynaptic accumulation of α-synuclein and LRRK2 in the brain.
    J Neurosci. 2012 May 30;32(22):7585-93 PMID: 22649237
  111. Altered splicing of ATP6AP2 causes X-linked parkinsonism with spasticity (XPDS).
    Hum Mol Genet. 2013 Aug 15;22(16):3259-68 PMID: 23595882
  112. Seven novel and stable translocations associated with oncogenic gene expression in malignant melanoma.
    Neoplasia. 2005 Apr;7(4):303-11 PMID: 15967107
  113. DJ-1 acts in parallel to the PINK1/parkin pathway to control mitochondrial function and autophagy.
    Hum Mol Genet. 2011 Jan 1;20(1):40-50 PMID: 20940149
  114. LRRK2 regulates autophagic activity and localizes to specific membrane microdomains in a novel human genomic reporter cellular model.
    Hum Mol Genet. 2009 Nov 1;18(21):4022-34 PMID: 19640926
  115. Regulation of an ATG7-beclin 1 program of autophagic cell death by caspase-8.
    Science. 2004 Jun 4;304(5676):1500-2 PMID: 15131264
  116. Augmenting CNS glucocerebrosidase activity as a therapeutic strategy for parkinsonism and other Gaucher-related synucleinopathies.
    Proc Natl Acad Sci U S A. 2013 Feb 26;110(9):3537-42 PMID: 23297226
  117. An independent replication of PARK16 in Asian samples.
    Neurology. 2010 Dec 14;75(24):2248-9 PMID: 21172849
  118. Segregation of a missense mutation in the microtubule-associated protein tau gene with familial frontotemporal dementia and parkinsonism.
    Hum Mol Genet. 1998 Oct;7(11):1825-9 PMID: 9736786
  119. Decreased activities of lysosomal acid alpha-D-galactosidase A in the leukocytes of sporadic Parkinson's disease.
    J Neurol Sci. 2008 Aug 15;271(1-2):168-73 PMID: 18495164
  120. VCP is essential for mitochondrial quality control by PINK1/Parkin and this function is impaired by VCP mutations.
    Neuron. 2013 Apr 10;78(1):65-80 PMID: 23498974
  121. Gaucher disease glucocerebrosidase and α-synuclein form a bidirectional pathogenic loop in synucleinopathies.
    Cell. 2011 Jul 8;146(1):37-52 PMID: 21700325
  122. LRRK2 G2019S as a cause of Parkinson's disease in North African Arabs.
    N Engl J Med. 2006 Jan 26;354(4):422-3 PMID: 16436781
  123. A novel SCARB2 mutation in progressive myoclonus epilepsy indicated by reduced β-glucocerebrosidase activity.
    J Neurol Sci. 2014 Apr 15;339(1-2):210-3 PMID: 24485911
  124. The genetics and neuropathology of Parkinson's disease.
    Acta Neuropathol. 2012 Sep;124(3):325-38 PMID: 22806825
  125. Alpha-synuclein-glucocerebrosidase interactions in pharmacological Gaucher models: a biological link between Gaucher disease and parkinsonism.
    Neurotoxicology. 2009 Nov;30(6):1127-32 PMID: 19576930
  126. Increased dimerization of alpha-synuclein in erythrocytes in Gaucher disease and aging.
    Neurosci Lett. 2012 Oct 24;528(2):205-9 PMID: 22981881
  127. Impaired parkin-mediated mitochondrial targeting to autophagosomes differentially contributes to tissue pathology in lysosomal storage diseases.
    Hum Mol Genet. 2012 Apr 15;21(8):1770-81 PMID: 22215441
  128. The new mutation, E46K, of alpha-synuclein causes Parkinson and Lewy body dementia.
    Ann Neurol. 2004 Feb;55(2):164-73 PMID: 14755719
  129. Upstream deregulation of calcium signaling in Parkinson's disease.
    Front Mol Neurosci. 2014 Jun 17;7:53 PMID: 24987329
  130. GTPase activity plays a key role in the pathobiology of LRRK2.
    PLoS Genet. 2010 Apr;6(4):e1000902 PMID: 20386743
  131. Hypoxic activation of the unfolded protein response (UPR) induces expression of the metastasis-associated gene LAMP3.
    Radiother Oncol. 2009 Sep;92(3):450-9 PMID: 19726095
  132. Link between the SNCA gene and parkinsonism.
    Neurobiol Aging. 2015 Mar;36(3):1505-18 PMID: 25554495
  133. The role of autophagy during the early neonatal starvation period.
    Nature. 2004 Dec 23;432(7020):1032-6 PMID: 15525940
  134. Impaired degradation of mutant alpha-synuclein by chaperone-mediated autophagy.
    Science. 2004 Aug 27;305(5688):1292-5 PMID: 15333840
  135. Synaptojanin 1 is required for endolysosomal trafficking of synaptic proteins in cone photoreceptor inner segments.
    PLoS One. 2014;9(1):e84394 PMID: 24392132
  136. The role of leucine-rich repeat kinase 2 (LRRK2) in Parkinson's disease.
    Nat Rev Neurosci. 2010 Dec;11(12):791-7 PMID: 21088684
  137. LRRK2 and GBA mutations differentially affect the initial presentation of Parkinson disease.
    Neurogenetics. 2010 Feb;11(1):121-5 PMID: 19458969
  138. A new locus for Parkinson's disease (PARK8) maps to chromosome 12p11.2-q13.1.
    Ann Neurol. 2002 Mar;51(3):296-301 PMID: 11891824
  139. Niemann-Pick disease type C1 predominantly involving the frontotemporal region, with cortical and brainstem Lewy bodies: an autopsy case.
    Neuropathology. 2014 Feb;34(1):49-57 PMID: 23711246
  140. Early-onset L-dopa-responsive parkinsonism with pyramidal signs due to ATP13A2, PLA2G6, FBXO7 and spatacsin mutations.
    Mov Disord. 2010 Sep 15;25(12):1791-800 PMID: 20669327
  141. Parkinsonism and Anderson Fabry's disease: a case report.
    Mov Disord. 2006 Jan;21(1):103-7 PMID: 16149089
  142. Lipid composition of membrane rafts, isolated with and without detergent, from the spleen of a mouse model of Gaucher disease.
    Biochem Biophys Res Commun. 2013 Dec 6;442(1-2):62-7 PMID: 24220330
  143. Genome-wide RNAi screen identifies the Parkinson disease GWAS risk locus SREBF1 as a regulator of mitophagy.
    Proc Natl Acad Sci U S A. 2014 Jun 10;111(23):8494-9 PMID: 24912190
  144. Mutations in the glucocerebrosidase gene and Parkinson's disease in Ashkenazi Jews.
    N Engl J Med. 2004 Nov 4;351(19):1972-7 PMID: 15525722
  145. Lysosome membrane lipid microdomains: novel regulators of chaperone-mediated autophagy.
    EMBO J. 2006 Sep 6;25(17):3921-33 PMID: 16917501
  146. Cerebrospinal fluid lysosomal enzymes and alpha-synuclein in Parkinson's disease.
    Mov Disord. 2014 Jul;29(8):1019-27 PMID: 24436092
  147. Cathepsin D is the main lysosomal enzyme involved in the degradation of alpha-synuclein and generation of its carboxy-terminally truncated species.
    Biochemistry. 2008 Sep 9;47(36):9678-87 PMID: 18702517
  148. Genetic inactivation of p62 leads to accumulation of hyperphosphorylated tau and neurodegeneration.
    J Neurochem. 2008 Jul;106(1):107-20 PMID: 18346206
  149. A two-stage meta-analysis identifies several new loci for Parkinson's disease.
    PLoS Genet. 2011 Jun;7(6):e1002142 PMID: 21738488
  150. Web-based genome-wide association study identifies two novel loci and a substantial genetic component for Parkinson's disease.
    PLoS Genet. 2011 Jun;7(6):e1002141 PMID: 21738487
  151. Autophagy fights disease through cellular self-digestion.
    Nature. 2008 Feb 28;451(7182):1069-75 PMID: 18305538
  152. Aberrant phosphorylation of alpha-synuclein in human Niemann-Pick type C1 disease.
    J Neuropathol Exp Neurol. 2004 Apr;63(4):323-8 PMID: 15099022
  153. Dopamine-modified alpha-synuclein blocks chaperone-mediated autophagy.
    J Clin Invest. 2008 Feb;118(2):777-88 PMID: 18172548
  154. Tau deletion impairs intracellular β-amyloid-42 clearance and leads to more extracellular plaque deposition in gene transfer models.
    Mol Neurodegener. 2014;9:46 PMID: 25384392
  155. Interaction between parkin and mutant glucocerebrosidase variants: a possible link between Parkinson disease and Gaucher disease.
    Hum Mol Genet. 2010 Oct 1;19(19):3771-81 PMID: 20643691
  156. A single mutation in MCCC1 or MCCC2 as a potential cause of positive screening for 3-methylcrotonyl-CoA carboxylase deficiency.
    Mol Genet Metab. 2012 Apr;105(4):602-6 PMID: 22264772
  157. Binding preference of p62 towards LC3-ll during dopaminergic neurotoxin-induced impairment of autophagic flux.
    Autophagy. 2011 Jan;7(1):51-60 PMID: 21045561
  158. Alzheimer's disease-related misfolded proteins and dysfunctional organelles on autophagy menu.
    DNA Cell Biol. 2015 Apr;34(4):261-73 PMID: 25664381
  159. RME-8 coordinates the activity of the WASH complex with the function of the retromer SNX dimer to control endosomal tubulation.
    J Cell Sci. 2014 May 1;127(Pt 9):2053-70 PMID: 24643499
  160. Membrane-bound α-synuclein interacts with glucocerebrosidase and inhibits enzyme activity.
    Mol Genet Metab. 2013 Jan;108(1):56-64 PMID: 23266198
  161. An association between the PARK16 locus and Parkinson's disease in a cohort from eastern China.
    Parkinsonism Relat Disord. 2011 Dec;17(10):737-9 PMID: 21840748
  162. Niemann-Pick C disease gene mutations and age-related neurodegenerative disorders.
    PLoS One. 2013;8(12):e82879 PMID: 24386122
  163. α-Synuclein: membrane interactions and toxicity in Parkinson's disease.
    Annu Rev Cell Dev Biol. 2010;26:211-33 PMID: 20500090
  164. Imputation of sequence variants for identification of genetic risks for Parkinson's disease: a meta-analysis of genome-wide association studies.
    Lancet. 2011 Feb 19;377(9766):641-9 PMID: 21292315
  165. Association of sequence alterations in the putative promoter of RAB7L1 with a reduced parkinson disease risk.
    Arch Neurol. 2012 Jan;69(1):105-10 PMID: 22232350
  166. Comprehensive research synopsis and systematic meta-analyses in Parkinson's disease genetics: The PDGene database.
    PLoS Genet. 2012;8(3):e1002548 PMID: 22438815
  167. Phenotypic variability in three families with valosin-containing protein mutation.
    Eur J Neurol. 2013 Feb;20(2):251-8 PMID: 22900631
  168. TFEB links autophagy to lysosomal biogenesis.
    Science. 2011 Jun 17;332(6036):1429-33 PMID: 21617040
  169. Early etiology of Alzheimer's disease: tipping the balance toward autophagy or endosomal dysfunction?
    Acta Neuropathol. 2015 Mar;129(3):363-81 PMID: 25556159
  170. Loss of PINK1 function promotes mitophagy through effects on oxidative stress and mitochondrial fission.
    J Biol Chem. 2009 May 15;284(20):13843-55 PMID: 19279012
  171. High sphingomyelin levels induce lysosomal damage and autophagy dysfunction in Niemann Pick disease type A.
    Cell Death Differ. 2014 Jun;21(6):864-75 PMID: 24488099
  172. Parkinson's disease.
    Lancet. 2009 Jun 13;373(9680):2055-66 PMID: 19524782
  173. A frequent LRRK2 gene mutation associated with autosomal dominant Parkinson's disease.
    Lancet. 2005 Jan 29-Feb 4;365(9457):412-5 PMID: 15680456
  174. LIMP-2 is a receptor for lysosomal mannose-6-phosphate-independent targeting of beta-glucocerebrosidase.
    Cell. 2007 Nov 16;131(4):770-83 PMID: 18022370
  175. Mitochondrial quality control mediated by PINK1 and Parkin: links to parkinsonism.
    Cold Spring Harb Perspect Biol. 2012 Nov;4(11). pii: a011338. doi: 10.1101/cshperspect.a011338 PMID: 23125018
  176. Membrane recruitment of endogenous LRRK2 precedes its potent regulation of autophagy.
    Hum Mol Genet. 2014 Aug 15;23(16):4201-14 PMID: 24682598
  177. Suppression of basal autophagy in neural cells causes neurodegenerative disease in mice.
    Nature. 2006 Jun 15;441(7095):885-9 PMID: 16625204
  178. PINK1 is selectively stabilized on impaired mitochondria to activate Parkin.
    PLoS Biol. 2010 Jan;8(1):e1000298 PMID: 20126261
  179. Phenotype, genotype, and worldwide genetic penetrance of LRRK2-associated Parkinson's disease: a case-control study.
    Lancet Neurol. 2008 Jul;7(7):583-90 PMID: 18539534
  180. Lysosomal degradation of alpha-synuclein in vivo.
    J Biol Chem. 2010 Apr 30;285(18):13621-9 PMID: 20200163
  181. Multicenter analysis of glucocerebrosidase mutations in Parkinson's disease.
    N Engl J Med. 2009 Oct 22;361(17):1651-61 PMID: 19846850
  182. The p.L302P mutation in the lysosomal enzyme gene SMPD1 is a risk factor for Parkinson disease.
    Neurology. 2013 Apr 23;80(17):1606-10 PMID: 23535491
  183. ATP13A2 regulates mitochondrial bioenergetics through macroautophagy.
    Neurobiol Dis. 2012 Mar;45(3):962-72 PMID: 22198378
  184. Inhibitors of LRRK2 kinase attenuate neurodegeneration and Parkinson-like phenotypes in Caenorhabditis elegans and Drosophila Parkinson's disease models.
    Hum Mol Genet. 2011 Oct 15;20(20):3933-42 PMID: 21768216
  185. Deficiency of ATP13A2 leads to lysosomal dysfunction, α-synuclein accumulation, and neurotoxicity.
    J Neurosci. 2012 Mar 21;32(12):4240-6 PMID: 22442086
  186. Sphingolipid storage induces accumulation of intracellular cholesterol by stimulating SREBP-1 cleavage.
    J Biol Chem. 2003 Jun 6;278(23):20961-70 PMID: 12657626
  187. FBXO7 mutations cause autosomal recessive, early-onset parkinsonian-pyramidal syndrome.
    Neurology. 2009 Jan 20;72(3):240-5 PMID: 19038853
  188. DJ-1 is critical for mitochondrial function and rescues PINK1 loss of function.
    Proc Natl Acad Sci U S A. 2010 May 25;107(21):9747-52 PMID: 20457924
  189. Regulation of neuronal survival factor MEF2D by chaperone-mediated autophagy.
    Science. 2009 Jan 2;323(5910):124-7 PMID: 19119233
  190. Gpnmb is a melanosome-associated glycoprotein that contributes to melanocyte/keratinocyte adhesion in a RGD-dependent fashion.
    Exp Dermatol. 2009 Jul;18(7):586-95 PMID: 19320736
  191. Vacuolar ATPases: rotary proton pumps in physiology and pathophysiology.
    Nat Rev Mol Cell Biol. 2007 Nov;8(11):917-29 PMID: 17912264
  192. Parkinson's disease-linked LRRK2 is expressed in circulating and tissue immune cells and upregulated following recognition of microbial structures.
    J Neural Transm (Vienna). 2011 May;118(5):795-808 PMID: 21552986
  193. ATP13A2 and Alpha-synuclein: a Metal Taste in Autophagy.
    Exp Neurobiol. 2014 Dec;23(4):314-23 PMID: 25548531
  194. LRRK2 Gly2019Ser penetrance in Arab-Berber patients from Tunisia: a case-control genetic study.
    Lancet Neurol. 2008 Jul;7(7):591-4 PMID: 18539535
  195. RAB7L1 interacts with LRRK2 to modify intraneuronal protein sorting and Parkinson's disease risk.
    Neuron. 2013 Feb 6;77(3):425-39 PMID: 23395371
  196. Lipid composition of microdomains is altered in a cell model of Gaucher disease.
    J Lipid Res. 2008 Aug;49(8):1725-34 PMID: 18427156
  197. Genotype-phenotype correlations between GBA mutations and Parkinson disease risk and onset.
    Neurology. 2008 Jun 10;70(24):2277-83 PMID: 18434642
  198. Drosophila ATP6AP2/VhaPRR functions both as a novel planar cell polarity core protein and a regulator of endosomal trafficking.
    EMBO J. 2013 Jan 23;32(2):245-59 PMID: 23292348
  199. Corticobasal degeneration and progressive supranuclear palsy share a common tau haplotype.
    Neurology. 2001 Jun 26;56(12):1702-6 PMID: 11425937
  200. Tau deletion exacerbates the phenotype of Niemann-Pick type C mice and implicates autophagy in pathogenesis.
    Hum Mol Genet. 2009 Mar 1;18(5):956-65 PMID: 19074461
  201. The Niemann-Pick C1 gene is downregulated by feedback inhibition of the SREBP pathway in human fibroblasts.
    J Lipid Res. 2008 May;49(5):1090-102 PMID: 18272927
  202. Loss of autophagy in the central nervous system causes neurodegeneration in mice.
    Nature. 2006 Jun 15;441(7095):880-4 PMID: 16625205
  203. The role of calcium and mitochondrial oxidant stress in the loss of substantia nigra pars compacta dopaminergic neurons in Parkinson's disease.
    Neuroscience. 2011 Dec 15;198:221-31 PMID: 21884755
  204. Dopaminergic neuronal loss, reduced neurite complexity and autophagic abnormalities in transgenic mice expressing G2019S mutant LRRK2.
    PLoS One. 2011;6(4):e18568 PMID: 21494637
  205. Cloning of the gene containing mutations that cause PARK8-linked Parkinson's disease.
    Neuron. 2004 Nov 18;44(4):595-600 PMID: 15541308
  206. Association of MAPT haplotypes with Alzheimer's disease risk and MAPT brain gene expression levels.
    Alzheimers Res Ther. 2014 Jul 01;6(4):39 PMID: 25324900
  207. Genetic screening for a single common LRRK2 mutation in familial Parkinson's disease.
    Lancet. 2005 Jan 29-Feb 4;365(9457):410-2 PMID: 15680455
Article Info
Journal
Autophagy
Abbr.
Autophagy
ISSN
1554-8635
Published
2015-00-00
Pages
1443-57
Language
English
Region
United States
NLM ID
101265188
PMCID
PMC4590678
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com